NEW YORK (GenomeWeb News) – Ventana Medical Systems has urged its shareholders again to reject Roche’s extended offer to buy the firm for $75 per share.
The offer marks the fifth time that Roche has sought to get approval from Ventana’s shareholders to acquire the firm for $75 per share, or roughly $3 billion. Ventana’s stock closed yesterday at $86.07 on the Nasdaq.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.